Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.75 USD
Change Today +0.09 / 5.42%
Volume 2.6M
CTIC On Other Exchanges
Symbol
Exchange
BrsaItaliana
NASDAQ CM
Frankfurt
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Silvano Spinelli

Executive Vice President of Development and Managing Director of European Operations, CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 2 board members in 1 different organizations across 2 different industries.

See Board Relationships
61--

Background*

Dr. Silvano Spinelli is a Co-founder of EOS S.p.A. and serves as its Chairman and Chief Executive Officer. Dr. Spinelli has been an Executive Vice President, Development and Managing Director of European Operations of Cell Therapeutics, Inc. since January 2004. Mr. Spinelli, who became part of CTI's management team as a result of the recently completed merger with Novuspharma, serves as Executive Vice President, Development for CTI and Managing Director of European Operations. ...

Read Full Background

Corporate Headquarters*

3101 Western Avenue
Seattle, Washington 98121

United States

Phone: 206-282-7100
Fax: 206-284-6206

Board Members Memberships*

Former Director and Managing Director
Co-Founder, Chairman of the Board and Chief Executive Officer
2004-N/A
Executive Vice President of Development and Managing Director of European Operations

Education*

Bachelor's Degree
Universita' di Pisa

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTIC:US $1.75 USD +0.09

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Ricardo J. Gonzalez Chief Executive Officer, President and Director
Navidea Biopharmaceuticals, Inc
$82.5K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CTI BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.